392 related articles for article (PubMed ID: 21482471)
1. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
2. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.
Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA
Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078
[TBL] [Abstract][Full Text] [Related]
3. The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells.
Androutsopoulos VP; Li N; Arroo RR
J Nat Prod; 2009 Aug; 72(8):1390-4. PubMed ID: 19601638
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
Androutsopoulos V; Arroo RR; Hall JF; Surichan S; Potter GA
Breast Cancer Res; 2008; 10(3):R39. PubMed ID: 18454852
[TBL] [Abstract][Full Text] [Related]
6. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism.
Androutsopoulos VP; Tsatsakis AM
Toxicol Lett; 2014 Oct; 230(2):304-13. PubMed ID: 23994263
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
8. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
[TBL] [Abstract][Full Text] [Related]
9. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
Doostdar H; Burke MD; Mayer RT
Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K
Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580
[TBL] [Abstract][Full Text] [Related]
11. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells.
Kasimsetty SG; Bialonska D; Reddy MK; Thornton C; Willett KL; Ferreira D
J Agric Food Chem; 2009 Nov; 57(22):10636-44. PubMed ID: 19919114
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
13. Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450.
Androutsopoulos V; Wilsher N; Arroo RR; Potter GA
Cancer Lett; 2009 Feb; 274(1):54-60. PubMed ID: 18976853
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort.
Chaudhary A; Willett KL
Toxicology; 2006 Jan; 217(2-3):194-205. PubMed ID: 16271822
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells.
Surichan S; Androutsopoulos VP; Sifakis S; Koutala E; Tsatsakis A; Arroo RR; Boarder MR
Food Chem Toxicol; 2012 Sep; 50(9):3320-8. PubMed ID: 22743247
[TBL] [Abstract][Full Text] [Related]
17. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes.
Surichan S; Arroo RR; Ruparelia K; Tsatsakis AM; Androutsopoulos VP
Food Chem Toxicol; 2018 Mar; 113():228-235. PubMed ID: 29408579
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
Androutsopoulos VP; Mahale S; Arroo RR; Potter G
Oncol Rep; 2009 Jun; 21(6):1525-8. PubMed ID: 19424633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
